Summary of Alignment Healthcare Q2 2026 Earnings Call

1Key Financial Results and Metrics

Health Plan Membership: Increased to 294,000, a 31% year-over-year growth.

Total Revenue: $1.3 billion, up 32% year-over-year.

Adjusted Gross Profit: $183 million, with an adjusted Medical Benefit Ratio (MBR) of 86.3%, improving by 40 basis points year-over-year.

Adjusted SG&A Expenses: $115 million, representing 8.6% of revenue, improved by 20 basis points year-over-year.

Adjusted EBITDA: $68 million, a 48% increase year-over-year, with an adjusted EBITDA margin of 5.1%.

Operating Cash Flow: $111 million generated in the first half of the year; cash and equivalents totaled $702 million.

2Strategic Updates and Business Highlights

The company continues to invest in its AVA Care Anywhere clinical teams and AI-powered stratification models, which enhance member engagement and predict hospital admissions.

Approximately 50% of members are in their first or second year, indicating significant embedded earnings potential, now estimated at $880 million.

Investments in core systems and operational efficiencies are aimed at improving clinical outcomes and scalability.

The company is focused on balancing growth with disciplined margin expansion and plans to invest in new market expansions and AI capabilities.

3Forward Guidance and Outlook

Full Year 2026 Guidance:

Membership expected between 298,000 and 301,000.

Revenue projected at $5.20 billion to $5.23 billion.

Adjusted gross profit forecasted between $630 million and $650 million.

Adjusted EBITDA anticipated in the range of $145 million to $163 million.

Q3 2026 Guidance:

Membership expected between 296,000 and 298,000.

Revenue forecasted at $1.30 billion to $1.32 billion.

Adjusted gross profit between $148 million and $158 million.

Adjusted EBITDA expected to range from $20 million to $30 million.

The company raised its revenue and adjusted gross profit guidance due to strong sales execution and confidence in achieving full-year objectives.

4Bad News, Challenges, or Points of Concern

The company noted a shift in seasonality expectations, with approximately 30% of full-year adjusted EBITDA expected in the second half, compared to 40% in the previous year, due to investments in clinical operations.

There were $6 million in unfavorable prior year development costs, which the company attributed to prudent reserve bolstering rather than operational issues.

Increased acuity in new member mix may lead to higher initial MLR, raising concerns about short-term profitability.

Competitive pressures are anticipated in 2027, with expectations of more aggressive competitors entering the market.

5Notable Q&A Insights

Management emphasized the importance of strategic investments in clinical operations and automation, which are expected to yield long-term benefits despite short-term cost increases.

The company is cautious about regulatory changes affecting the MA landscape, particularly regarding STAR ratings, and is focused on maintaining a fair regulatory environment.

There is a deliberate strategy to manage risk and align with providers, which is expected to enhance operational efficiency and member care.

The leadership expressed confidence in their ability to achieve growth targets while navigating the complexities of the healthcare market. Overall, Alignment Healthcare reported strong financial results while outlining a strategic focus on growth, operational efficiency, and member engagement, despite facing some challenges and competitive pressures.